Search company, investor...

Applied Spectral Imaging

spectral-imaging.com

Stage

Acquired | Acquired

Valuation

$0000 

About Applied Spectral Imaging

Applied Spectral Imaging (ASI) develops imaging systems for the life sciences and health care sectors, focusing on the markets for pathology and cytogenetics, which is the diagnosis of chromosome anomalies. ASI's spectral imaging technology and software use the properties of light to reveal information on an image that other techniques can't display, thereby improving the ability to make a diagnosis.

Headquarters Location

2 HaCarmel Street Alon Building B

Yoqnea'm, 20692,

Israel

+972 4 654 7567

Missing: Applied Spectral Imaging's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Applied Spectral Imaging's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Applied Spectral Imaging

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Applied Spectral Imaging is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Applied Spectral Imaging Patents

Applied Spectral Imaging has filed 1 patent.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Ion source
  • Mass spectrometry
patents chart

Application Date

Grant Date

Title

Related Topics

Status

12/15/2016

5/18/2021

Digital photography, Image processing, Spectroscopy, Image sensors, Imaging

Grant

Application Date

12/15/2016

Grant Date

5/18/2021

Title

Related Topics

Digital photography, Image processing, Spectroscopy, Image sensors, Imaging

Status

Grant

Latest Applied Spectral Imaging News

CLP August/September 2022 Tech Guide: Anatomic and Digital Pathology Instruments and Tools

Sep 13, 2022

The CLP August/September 2022 Tech Guide that appears in Clinical Lab Products (CLP) features a wide-range of products from top laboratory providers. The 11 providers who took part in the Tech Guide, include: Applied Spectral Imaging, Aurora mScope, BioGenex, Gestalt Diagnostics, Mikroscan, Nikon Instruments Inc ., NovoPath, Proscia, Tribun Health, and Visiopharm. The August/September issue also features a second Tech Guide on point-of-care assays and analyzers. Each Tech Guide that appears in CLP focuses on a specific topic area. The once-a-year opportunity, gives providers a spotlight to share product information and for readers to make side-by-side, apples-to-apples comparisons on these products. Contact information is provided in each listing, so readers can directly contact the company about the product or products that interest them most. These listings are posted at no charge and are solicited from the CLP staff via e-mail. Upcoming Tech Guides include molecular diagnostics. In addition to the CLP August/September 2022 Tech Guide, the current issue of CLP also includes Product Spotlights on toxicology, lab automation, and a roundup of product news from around the industry. These are short, descriptions of the products that include a full-color, high-res photograph. Again these products are posted at no charge, and include full contact information, so readers can contact the provider for more information. The August/September issue features three in-depth articles, including the cover story on the difficulties of diagnosing congenital CMV. Other articles include, privacy considerations about health data and true color rendering in digital microscopy. The May/June 2022 Tech Guide is available  here  as a free download. Share:

Applied Spectral Imaging Frequently Asked Questions (FAQ)

  • Where is Applied Spectral Imaging's headquarters?

    Applied Spectral Imaging's headquarters is located at 2 HaCarmel Street, Yoqnea'm.

  • What is Applied Spectral Imaging's latest funding round?

    Applied Spectral Imaging's latest funding round is Acquired.

  • Who are the investors of Applied Spectral Imaging?

    Investors of Applied Spectral Imaging include Danaher, Gemini Israel Ventures and The Challenge Fund-Etgar.

  • Who are Applied Spectral Imaging's competitors?

    Competitors of Applied Spectral Imaging include Seno Medical Instruments, HyperMed Imaging, Proterixbio, BioImagene, Amicas and 13 more.

Compare Applied Spectral Imaging to Competitors

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

I
Imorphics Limited

Imorphics is a spin-out from the Division of Imaging Science and Biomedical Engineering in the Faculty of Medicine and is based on more than 20 year's research led by Professor Chris Taylor. The company sells 3D medical image analysis software which is being used to improve the speed and accuracy of measurements taken in drug trials. MTF introduced Chairman Mike Bowes to the company. Mike Bowes was previously CEO of Kestra, an imaging start-up backed by 3i which was sold in 1999.

I
InstaRecon

InstaRecon is a groundbreaking imaging technology company that aims to provide image formation solutions for computer tomography that have unparalleled speed. Image formation in the latest medical CT scanners lags data acquisition by a factor of 20. The speedups provided by InstaRecon are needed to overcome the computational bottleneck, enabling new features of real-time imaging, improved image quality, and reduced radiation-dose imaging, at reduced costs.

N
Nervonix

Nervonix, Inc. is a medical device company that has invented, patented, and prototyped a break-through nerve imaging technology that operates non-invasively at the skin surface to accurately locate and image peripheral nerves.

N
National P.E.T. Scan

National P.E.T. Scan is a provider of diagnostic imaging services with four freestanding outpatient positron emission tomography/computerized tomography ("PET-CT") facilities in Florida.

D
Digital Medics

Digital Medics GmbH is a producer of technology in the area of radiology software and equipment.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.